Skip to content

Effects of rTMS on Brain Activation in Aphasia

Immediate and Cumulative Effects of rTMS on Brain Activation in Chronic Aphasia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03292471
Enrollment
16
Registered
2017-09-25
Start date
2018-01-01
Completion date
2019-12-31
Last updated
2022-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aphasia, Acquired

Keywords

Aphasia, Rehabilitation, Stroke

Brief summary

This study will investigate the use of repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation method, to improve word-finding abilities in Veterans and non-Veterans with chronic language problems following stroke (aphasia). Improving word-finding is important because word-finding difficulties are among the most common and debilitating consequences of aphasia. Although rTMS has shown promise as a treatment approach, not all individuals with aphasia show the same level of benefit. Specifically, this study will use functional magnetic resonance imaging (fMRI) to examine whether the likelihood of improved word-finding abilities following rTMS depends on pre-intervention language-related brain activity and will examine changes in brain activity in response to stimulation. A better understanding of how and for whom rTMS works will 1) help to identify the best candidates for rTMS treatment, 2) optimize rTMS treatment protocols to improve patient outcomes, and 3) improve the investigators' understanding of how the brain re-organizes language functions following stroke.

Detailed description

Aphasia, an acquired communication disorder, is a common consequence of left-hemisphere stroke. Persisting, or chronic, aphasia negatively impacts not only interpersonal communication but participation in activities of daily living, independence, and autonomy. It is also associated with higher rates of depression and lower quality of life. Therefore, examining factors and treatments that result in the best possible recovery of language function for individuals with chronic aphasia is of paramount importance. An intervention approach that has shown promise in early-phase research on treatment of chronic aphasia is repetitive transcranial magnetic stimulation (rTMS). rTMS is a non-invasive brain stimulation technique that can be used to focally modulate activity in targeted brain regions. Studies have shown that multiple sessions of 1Hz inhibitory rTMS applied to the right hemisphere Pars Triangularis (PTr) of people with chronic aphasia results in improved naming abilities. These improvements accrue over time, and may persist even after rTMS has ended. It has been proposed that rTMS induces this improvement by reducing the disruptive influence of compensatory activity in the right hemisphere PTr, allowing for recruitment of more efficient left hemisphere peri-lesional brain areas. However, existing neuroimaging evidence to support this hypothesis is insufficient. The goal of the proposed study is to investigate the neurological mechanisms underlying the effect of rTMS on naming performance in chronic aphasia. This will extend existing knowledge regarding hemispheric contributions to language recovery following stroke and elucidate how rTMS-induced neuroplasticity can be co-opted to encourage optimal reorganization. The study will also investigate a potential source of individual response variability to rTMS, one which can inform both candidate selection and optimal stimulation parameters. Sixteen participants will be enrolled, yielding a significantly larger sample size than previous studies that have examined changes in functional brain activation in response to rTMS (n = 1, 2). All participants will receive a sequence of 1200 pulses of 1 Hz rTMS to right hemisphere PTr across 10 daily sessions. Half of the participants will also receive a 6 Hz rTMS excitatory priming pulse sequence immediately prior to the 1 Hz sequence. This priming sequence ensures a consistent inhibitory response to the subsequent 1Hz rTMS and will permit an examination of state-dependent individual response variability. To evaluate the effect of rTMS over time, participants will undergo functional magnetic resonance (fMRI) scans at four time points: prior to initiation of rTMS (baseline), immediately following the first rTMS session (post-rTMS), following the conclusion of the rTMS series (post-treatment) and at a 2-month follow-up visit. During the scans, participants will be asked to name pictures, and both patterns of regional naming-related activation and effective connectivity (directional causal influence between activated brain regions) will be evaluated at each time point. In addition, naming performance will be measured via standardized assessments at baseline, post-treatment, and follow-up. Changes in naming performance will be assessed over time, as a measure of rTMS effectiveness overall and between groups (priming sequence vs no priming sequence). In addition, changes in activation and effective connectivity will be correlated with naming improvement to assess the relative effectiveness of right hemisphere recruitment compared to left hemisphere peri-lesional recruitment. Overall increases in left hemisphere recruitment are hypothesized to result in greater improvements. However, the magnitude of left hemisphere recruitment due to rTMS is expected to depend on baseline levels of right hemisphere PTr activity. Results from this study will significantly improve the investigator's understanding of the effects of rTMS on stroke recovery. The results will also inform future studies evaluating rTMS as an adjunct to behavioral speech-language intervention, augmenting therapeutic gains from traditional aphasia treatment.

Interventions

DEVICETranscranial Magnetic Stimulation

rTMS is a non-invasive brain stimulation technique in which a focal, time-varying magnetic field is applied to a specific brain area to induce neuronal depolarization. rTMS can be used to selectively target a given brain region with a resolution as focal as 0.5 cm3 .Typically, administering a slow (1 Hz) sequence of magnetic pulses via rTMS temporarily reduces cortical excitability in the targeted brain region.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Participants will be assigned to receive 10 sessions of inhibitory rTMS to right hemisphere pars triangularis (RH PTr), either preceded by a 6 Hz priming rTMS stimulation sequence or not.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aphasia due to unilateral left-hemisphere stroke * Greater than 6 months post aphasia onset * English as a first language * No contraindications to MRI or TMS including: * pregnancy * presence of ferromagnetic substances in the head with the exception of dental fillings, stents or aneurysm clips documented to be MRI compatible * presence of any implanted devices including cardiac pacemaker, implanted cardiac defibrillator, insulin pump, cochlear implant, or drug infusion device * history of epilepsy; use of medications that are known to lower seizure threshold * severe claustrophobia

Exclusion criteria

* History for progressive neurological disease or premorbid language disorder * Presence of severe motor speech disorder * Drug or alcohol dependence, or significant mood or behavioral disorder that is not currently stable or medically managed

Design outcomes

Primary

MeasureTime frameDescription
Change in Philadelphia Naming Test (PNT) PerformancePre- to post treatment (an average of 3 weeks), and at 2 month follow-upThe Philadelphia Naming Test is a performance-based measure commonly used to assess naming (word production) ability among adults with aphasia. The minimum raw score is 0 and the maximum is 175 (higher scores reflect more accurate naming/better naming ability).

Secondary

MeasureTime frameDescription
Change in Comprehensive Aphasia Test (CAT) PerformancePre- to post treatment (an average of 3 weeks), and at 2 month follow-upThe Comprehensive Aphasia Test is a performance-based measure of language processing across multiple language domains commonly used to assess language-processing ability among adults with aphasia. CAT mean modality T-Score (average of all language subscale T-scores of the Comprehensive Aphasia Test) is a measure of overall aphasia severity. A T-score of 50 reflects mean performance for the CAT normative sample of individuals with aphasia, with a standard deviation of 10 (higher scores reflect better performance/less severe aphasia).

Countries

United States

Participant flow

Pre-assignment details

Prior to group assignment, participants completed the Comprehensive Aphasia Test to determine aphasia severity, as groups were pseudorandomized on this basis (groups were balanced for average aphasia severity). In addition, participants completed an MRI screener and medical records were reviewed to screen for the presence of contraindications to MRI and/or rTMS.

Participants by arm

ArmCount
Inhibitory Only
Inhibitory 1Hz rTMS was applied continuously for 1200 pulses (20 minutes) 5 days per week across 2 weeks (10 sessions total).
8
Excitatory Primed
The inhibitory sequence (1Hz rTMS was applied continuously for 1200 pulses) was preceded for each session by priming stimulation which will consist of intermittent 6-Hz rTMS applied in 5 second trains with 25 second intervals between trains for a total 600 pulses (10 minutes).
8
Total16

Baseline characteristics

CharacteristicExcitatory PrimedTotalInhibitory Only
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
5 Participants8 Participants3 Participants
Age, Categorical
Between 18 and 65 years
3 Participants8 Participants5 Participants
Aphasia Severity (Comprehensive Aphasia Severity Mean Modality T-Score)53.86 T-Score
STANDARD_DEVIATION 4.29
53.64 T-Score
STANDARD_DEVIATION 4.67
53.56 T-Score
STANDARD_DEVIATION 5.25
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
8 Participants16 Participants8 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
2 Participants4 Participants2 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
6 Participants12 Participants6 Participants
Region of Enrollment
United States
8 Participants16 Participants8 Participants
Sex: Female, Male
Female
2 Participants3 Participants1 Participants
Sex: Female, Male
Male
6 Participants13 Participants7 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 80 / 8
other
Total, other adverse events
0 / 81 / 8
serious
Total, serious adverse events
0 / 80 / 8

Outcome results

Primary

Change in Philadelphia Naming Test (PNT) Performance

The Philadelphia Naming Test is a performance-based measure commonly used to assess naming (word production) ability among adults with aphasia. The minimum raw score is 0 and the maximum is 175 (higher scores reflect more accurate naming/better naming ability).

Time frame: Pre- to post treatment (an average of 3 weeks), and at 2 month follow-up

Population: 5 participants in each group were able to return for 2-month follow up testing

ArmMeasureGroupValue (MEAN)Dispersion
Inhibitory OnlyChange in Philadelphia Naming Test (PNT) PerformancePre-treatment122.125 Score on a scaleStandard Deviation 27.18
Inhibitory OnlyChange in Philadelphia Naming Test (PNT) PerformancePost-treatment132.5 Score on a scaleStandard Deviation 28.65
Inhibitory OnlyChange in Philadelphia Naming Test (PNT) PerformanceFollow-up115.6 Score on a scaleStandard Deviation 21.85
Excitatory PrimedChange in Philadelphia Naming Test (PNT) PerformancePost-treatment142.125 Score on a scaleStandard Deviation 16.71
Excitatory PrimedChange in Philadelphia Naming Test (PNT) PerformancePre-treatment130.875 Score on a scaleStandard Deviation 22.86
Excitatory PrimedChange in Philadelphia Naming Test (PNT) PerformanceFollow-up133.6 Score on a scaleStandard Deviation 26.84
Comparison: Baysian Multivariate Analysis of Variance95% CI: [-2.07, 2.92]
Comparison: Baysian Multivariate Analysis of Variance95% CI: [-2.38, 2.46]
Secondary

Change in Comprehensive Aphasia Test (CAT) Performance

The Comprehensive Aphasia Test is a performance-based measure of language processing across multiple language domains commonly used to assess language-processing ability among adults with aphasia. CAT mean modality T-Score (average of all language subscale T-scores of the Comprehensive Aphasia Test) is a measure of overall aphasia severity. A T-score of 50 reflects mean performance for the CAT normative sample of individuals with aphasia, with a standard deviation of 10 (higher scores reflect better performance/less severe aphasia).

Time frame: Pre- to post treatment (an average of 3 weeks), and at 2 month follow-up

Population: 5 participants in each group were able to return for follow-up testing

ArmMeasureGroupValue (MEAN)Dispersion
Inhibitory OnlyChange in Comprehensive Aphasia Test (CAT) PerformancePre-treatment53.56 T-ScoreStandard Deviation 5.25
Inhibitory OnlyChange in Comprehensive Aphasia Test (CAT) PerformancePost-treatment54.54 T-ScoreStandard Deviation 5.45
Inhibitory OnlyChange in Comprehensive Aphasia Test (CAT) PerformanceFollow-up52.5 T-ScoreStandard Deviation 4.04
Excitatory PrimedChange in Comprehensive Aphasia Test (CAT) PerformancePre-treatment53.875 T-ScoreStandard Deviation 4.29
Excitatory PrimedChange in Comprehensive Aphasia Test (CAT) PerformancePost-treatment55.71 T-ScoreStandard Deviation 4.59
Excitatory PrimedChange in Comprehensive Aphasia Test (CAT) PerformanceFollow-up56.7 T-ScoreStandard Deviation 5.3
Comparison: Baysian Multivariate Analysis of Variance95% CI: [-0.0719, 2.25]
Comparison: Baysian Multivariate Analysis of Variance95% CI: [-0.596, 1.58]

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026